The Detection of Epstein—Barr Virus Receptors Utilizing Radiolabelled Virus

References

1. Adams A. 1975; Epstein-Barr virus production, concentration and purification. IARC Internal Technical Report No. 75003 pp 129–146
   [Google Scholar]
2. Baird S., Raschke W., Weissman I. 1977; Evidence that MuLV-induced thymic lymphoma cells possess specific cell membrane binding sites for MuLV. International Journal of Cancer 19:403–413
   [Google Scholar]
3. Dolynuik M., Pritchet R., Kieff E. 1976; Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. Journal of Virology 17:935–949
   [Google Scholar]
4. Epstein M. A., Achong B., Barr Y., Zujac B., Henle G., Henle W. 1966; Morphological and virological investigation of cultured Burkitt tumor lymphoblasts (strain Raji). Journal of the National Cancer Institute 37:547–559
   [Google Scholar]
5. Jondal M., Klein G., Oldstone M., Bokish V., Yefenof E. 1976; Surface markers on human B and T lymphocytes. VIII. Scandinavian Journal of Immunology 5:401–410
   [Google Scholar]
6. Klein G., Giovanella B., Westman A., Stehlin I., Mumford D. 1976; An EBV-genome-negative cell line established from an American Burkitt lymphoma: receptor characteristics. EBV infectability and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5:319–334
   [Google Scholar]
7. Klein G., Yefenof E., Falk K., Westman A. 1978; Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV-receptor/complement receptor complex in a series of sublines derived from the same original Burkitt’s lymphoma. International Journal of Cancer 21:552–560
   [Google Scholar]
8. Klein G., Manneborg A., Steinitz M. 1979; Differences in EBV receptor concentration between in vitro EBV-converted lymphoma sublines reflect biological differences between the converting viral substrains. International Journal of Cancer 23:197–200
   [Google Scholar]
9. Longberg-Holm K., Korant B. D. 1972; Early interaction of Rhinoviruses with host cells. Journal of Virology 9:29–40
   [Google Scholar]
10. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
11. Menezes J., Sergneuron J. M., Patel P., Bourkas A., Lenoir G. 1977; Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt-4). Journal of Virology 22:816–821
    [Google Scholar]
12. Reedman B., Klein G. 1973; Cellular localisation of an Epstein-Barr virus (EBV)-associated complementfixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11:499–520
    [Google Scholar]
13. Sairenji T., Hinuma Y. 1973; Relationship between the synthesis of Epstein-Barr virus and growth of host cell on a Burkitt lymphoma cell line P3HR-1. Gann 64:583–590
    [Google Scholar]
14. Schulte-Holthausen H., Zur Hausen H. 1970; Partial purification of the Epstein-Barr virus and some properties of its DNA. Virology 40:776–779
    [Google Scholar]
15. Volsky D. J., Loyter A. 1978; Role of Ca⁺⁺ in virus-induced membrane fusion: Ca⁺⁺ accumulation and ultrastructural changes induced by Sendai virus in chicken erythrocytes. Journal of Cell Biology 78:465–479
    [Google Scholar]